EcoDrugPlus

Ribosomal Protein L14

Ensembl ID : ENSLCAG00010024545
Gene Symbol: LOC108900376
4 Cross references
309 Possible Orthologues:

Ribosomal Protein L17

Ensembl ID : ENSLCAG00010018008
Gene Symbol: LOC108875549
4 Cross references
710 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSLCAG00010023638
Gene Symbol: LOC108885891
4 Cross references
379 Possible Orthologues:

Ribosomal Protein L18a

Ensembl ID : ENSLCAG00010020846
Gene Symbol: LOC108882413
4 Cross references
364 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSLCAG00010023677
Gene Symbol: RPL19
4 Cross references
287 Possible Orthologues:

Ribosomal Protein L21

Ensembl ID : ENSLCAG00010012661
Gene Symbol: LOC108881762
4 Cross references
784 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSLCAG00010017643
Gene Symbol: RPL22
3 Cross references
198 Possible Orthologues:

Ribosomal Protein L23

Ensembl ID : ENSLCAG00010014003
Gene Symbol: LOC108898496
4 Cross references
230 Possible Orthologues:

Ribosomal Protein L24

Ensembl ID : ENSLCAG00010023664
Gene Symbol: LOC108901081
4 Cross references
318 Possible Orthologues:

Ribosomal Protein L26

Ensembl ID : ENSLCAG00010007402
Gene Symbol: RPL26
1 Cross references
422 Possible Orthologues:

Ribosomal Protein L27

Ensembl ID : ENSLCAG00010014966
Gene Symbol: LOC108888627
4 Cross references
370 Possible Orthologues:

Ribosomal Protein L27a

Ensembl ID : ENSLCAG00010002788
Gene Symbol: RPL27A
4 Cross references
514 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).